Home page > Nieuws
 

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Nieuws

 

 
Chiesi Global Rare Diseases Announces Publication of Results from Phase 3 BALANCE Study in Fabry Disease
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, today announced the publication of...
1/20
ARCHIEF
2022 for Chiesi: The Group’s international growth continues
Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases
Chiesi appoints Giuseppe Accogli as new Group CEO
Chiesi accelerates path toward full sustainability despite Covid-19 pandemic
Wereld Astma Dag 2021: Persbericht
CHIESI CONTINUES CULTURAL TRANSFORMATION WITH NEW VISUAL IDENTITY THAT MIRRORS PATIENTS’ LANGUAGE AND EXPERIENCES
Chiesi Group: performance is up in 2020
Europese marktautorisatie voor de extrafijne drievoudige combinatietherapie
SAMENWERKING TUSSEN KAIA HEALTH EN DE CHIESI GROEP
COPD Dag 2020
Samenwerking tussen Moderna en de Chiesi Groep
10 Jaar Chiesi België
Chiesi publishes its annual report
Climbing For Life
Zondag 31 mei - Werelddag zonder tabak
Domus Medica
Chiesi België & COVID-19 Pandemic